Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Non-Current Deferred Tax Liability (2021)

Inmune Bio's Non-Current Deferred Tax Liability history spans 1 years, with the latest figure at $257000.0 for Q4 2021.

  • For Q4 2021, Non-Current Deferred Tax Liability changed N/A year-over-year to $257000.0; the TTM value through Dec 2021 reached $257000.0, changed N/A, while the annual FY2021 figure was $257000.0, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2021 was $257000.0 at Inmune Bio.
  • Across five years, Non-Current Deferred Tax Liability topped out at $257000.0 in Q4 2021 and bottomed at $257000.0 in Q4 2021.